Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456138
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-05
Brief Title:
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Sponsor:
Shanghai Chest Hospital
Organization:
Shanghai Chest Hospital